Diabetes in the elderly: The geriatrician's perspective

Canadian Journal of Diabetes

Volumn 27, Issue 2, 2003, Pages 172-175

  Sclater, Anne ^a,b,c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b Capital Health Edmonton   (Canada)

^c GLENROSE REHABILITATION HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA GLUCOSIDASE INHIBITOR; ANTIDIABETIC AGENT; METFORMIN; PIOGLITAZONE; ROSIGLITAZONE; SULFONYLUREA DERIVATIVE; TROGLITAZONE;

AGED; CLINICAL FEATURE; DIABETES MELLITUS; DIARRHEA; ELDERLY CARE; FLATULENCE; HUMAN; LIVER TOXICITY; PATHOGENESIS; REVIEW;

EID: 0041969785     PISSN: 14992671     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Meneilly GS, Tessier D. Diabetes in elderly adults. J Gerontol A Biol Sci Med Sci. 2001;56:M5-M13.
2. Rockwood K, Awalt E, MacKnight C, McDowell I. Incidence and outcomes of diabetes mellitus in elderly people: report from the Canadian Study of Health and Aging. CMAJ. 2000;162:769-772.
3. Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care. 1998;21:518-524.
4. , Boyle JP, Honeycutt AA, Narayan KM, et al. Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S. Diabetes Care. 2001;24:1936-1940.
5. Franse LV, Di Bari M, Shorr RI, et al. Type 2 diabetes in older well-functioning people: who is undiagnosed? Data from the Health, Aging, and Body Composition Study. Diabetes Care. 2001;24:2065-2070.
6. Spence JC. Some observations on sugar tolerance, with special reference to variations found at different ages. Q J Med. 1920;14:314.
7. Davidson MB. The effect of aging on carbohydrate metabolism: a review of the English literature and a practical approach to the diagnosis of diabetes mellitus in the elderly. Metabolism. 1979;28:688-705.
8. Morley JE, Mooradian AD, Rosenthal MJ, Kaiser FE. Diabetes mellitus in elderly patients. Is it different? Am J Med. 1987;83:533-544.
9. Morrow LA, Halter JB. Carbohydrate metabolism in the elderly. In: Sowers JR, Felicelta JU, eds. The Endocrinology of Aging. New York, NY: Raven Press; 1988.
10. Rewers M, Hamman RF. Risk factors for non-insulin-dependent diabetes. In: Diabetes in America. 2nd ed. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health; 1995:179-220.
11. Vaag A, Henriksen JE, Madsbad S, et al. Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus. J Clin Invest. 1995;95:690-698.
12. Feskens EJ, Boer JM, van Dam RM, et al. Diabetes prevalence in offspring of elderly men with known and newly diagnosed diabetes [letter]. Diabetes Care. 1999;22:1919.
13. Eriksson KF, Lindgarde F. Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise: the 6-year Malmo feasibility study. Diabetologia. 1991;34:891-898.
14. Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. Diabetes Care. 1997;20:537-544.
15. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343-1350.
16. Edelstein SL, Knowler WC, Bain RP, et al. Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies. Diabetes. 1997;46:701-710.
17. Barsh GS, Farooqi IS, O'Rahilly S. Genetics of body-weight regulation. Nature. 2000;404:644-651.
18. The Diabetes Prevention Program Research Group. The Diabetes Prevention Program: baseline characteristics of the randomized cohort. Diabetes Care. 2000;23:1619-1629.
19. Wadden TA, Sternberg JA, Letizia KA, et al. Treatment of obesity by very low calorie diet, behavior therapy, and their combination: a five-year perspective. Int J Obes. 1989;13(suppl 2):39-46.
20. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21:1414-1431.
21. Pandit MK, Burke J, Gustafson AB, et al. Drug-induced disorders of glucose tolerance. Ann Intern Med. 1993;118:529-539.
22. Chan JC, Cockram CS, Critchley JA. Drug-induced disorders of glucose metabolism: mechanisms and management. Drug Saf. 1996;15:135-157.
23. Procyshyn RM, Pande S, Tse G. New-onset diabetes mellitus associated with quetiapine. Can J Psychiatry. 2000;45:668-669.
24. Bettinger TL, Mendelson SC, Dorson PG, Crismon ML. Olanzapine-induced glucose dysregulation. Ann Pharmacother. 2000;34:865-867.
25. Conley RR, Meltzer HY. Adverse events related to olanzapine. J Clin Psychiatry. 2000;61(suppl 8):26-29.
26. Ober SK, Hudak R, Rusterholtz A. Hyperglycemia and olanzapine [letter]. Am J Psychiatry. 1999;156:970.
27. Goldstein LE, Sporn J, Brown S, et al. New-onset diabetes mellitus and diabetic ketoacidosis associated with olanzapine treatment. Psychosomatics. 1999;40:438-443.
28. Goldstein LE, Henderson DC. Atypical antipsychotic agents and diabetes mellitus. Primary Psychiatry. 2000;7:65-68.
29. Henderson DC, Cagliero E, Gray C, et al. Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: a five-year naturalistic study. Am J Psychiatry. 2000;157:975-981.
30. Luna B, Feinglos MN. Drug-induced hyperglycemia JAMA. 2001;286:1945-1948.
31. Meneilly GS, Elliott T, Tessier D, et al. NIDDM in the elderly. Diabetes Care. 1996;19:1320-1325.
32. Arner P, Pollare T, Lithell H. Different aetiologies of type 2 (non-insulin-dependent) diabetes mellitus in obese and non-obese subjects. Diabetologia. 1991;4:483-487.
33. Meneilly GS, Elliott T. Metabolic alterations in middle-aged and elderly obese patients with type 2 diabetes. Diabetes Care. 1999;22:112-118.
34. Morley JE. Diabetes mellitus: a major disease of older persons [editorial]. J Gerontol A Biol Sci Med Sci. 2000;55:M255-M256.
35. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2002;25(suppl 1):S5-S20.
36. Meltzer S, Lawrence L, Daneman D, et al. 1998 clinical practice guidelines for the management of diabetes in Canada. CMAJ. 1998;159(suppl 8):S1-S29.
37. Meneilly GS, Ryan EA, Radziuk J, et al. Effect of acarbose on insulin sensitivity in elderly patients with diabetes. Diabetes Care. 2000;23:1162-1167.
38. Johnston PS, Lebovitz HE, Coniff RF, et al. Advantages of α-glucosidase inhibition as monotherapy in elderly type 2 diabetic patients. J Clin Endocrinol Metab. 1998;83:1515-1522.
39. Inzucchi SE. Oral antihyperglycemic therapy for type 2 diabetes: scientific review. JAMA. 2002;287:360-372.
40. Beebe K, Patel J. Rosiglitazone is effective and well tolerated in patients ≥65 years with type 2 diabetes [abstract]. Diabetes. 1999;48:111A. Abstract 0479.
41. Wolffenbuttel BH, Sels JP, Rondas-Colbers GJ, et al. Comparison of different insulin regimens in elderly patients with NIDDM. Diabetes Care. 1996;19:1326-1332.
42. Brodows R, Chessor R. A comparison of premixed insulin preparations in elderly patients. Efficacy of 70/30 and 50/50 human insulin mixtures. Diabetes Care. 1995;18:855-857.